Home・Lista de Ações・Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc

Fechado

SetorSaúde

575.5 -0.21

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

562.67

Máximo

577.21

Indicadores-chave
By Trading Economics
Rendimento	85M 1.7B
Vendas	989M 12B
P/E Médio do Setor	30.575 64.641
EPS	6.03
Rendimento de Dividendos	0.15
Margem de lucro	14.516
Funcionários	125,000
EBITDA	262M 2.6B

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+6.98% upside

Dividendos
By Acuity
Rendimento de Dividendos Médio do Setor	0.15% 2.31%
Próximos Ganhos	21 de out. de 2026
Próxima data de dividendos	15 de out. de 2026
Próxima data de ex-dividendo	15 de set. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	17B 213B
Abertura anterior	575.71
Fecho anterior	575.5

Sentimento de Notícias

By Acuity

23%

77%

66 / 340 Ranking em Healthcare

Thermo Fisher Scientific Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

31 de jul. de 2026, 22:41 UTC

Correlated Moves

Thermo Fisher Scientific Inc. shares are lower in after-market trading, influenced by a broader market decline and rising U.S. Treasury yields amid inflation concerns.

30 de jul. de 2026, 19:09 UTC

Correlated Moves

Thermo Fisher Scientific Inc shares are lower amid mixed economic data, including rising jobless claims and disappointing Q2 GDP growth.

29 de jul. de 2026, 23:16 UTC

Thermo Fisher Scientific shares are trading roughly flat in after-market hours. The stock remains above its 20-day moving average and near its one-month range.

28 de jul. de 2026, 18:06 UTC

News

Social Media

Thermo Fisher Scientific shares reached a 25-week high of $588.48, reflecting strong upward momentum despite a recent pullback from earlier session highs.

27 de jul. de 2026, 18:01 UTC

Thermo Fisher Scientific Inc. shares are lower today amid a broader market reaction to falling oil prices, despite easing geopolitical tensions surrounding Iran.

24 de jul. de 2026, 19:23 UTC

News

Social Media

Thermo Fisher Scientific shares are lower today despite strong Q2 results and revenue of $11.99 billion. Barclays and Deutsche Bank raised price targets to $650 and $635, respectively.

23 de jul. de 2026, 23:01 UTC

Thermo Fisher Scientific shares declined in after-market trading, touching a session low before a slight recovery. The stock remains above its 20-day moving average.

22 de jul. de 2026, 23:02 UTC

Social Media

Thermo Fisher Scientific is set to report earnings, with analysts estimating revenue of $11.71 billion and EPS of $5.72. Shares are higher in after-market trading.

21 de jul. de 2026, 22:01 UTC

Thermo Fisher Scientific shares are higher in after-market hours, supported by positive market sentiment from strong earnings reports, despite recent lower finishes.

20 de jul. de 2026, 19:46 UTC

Shares of Thermo Fisher Scientific Inc. are lower today, reflecting routine intraday fluctuations within the asset's one-month trading range.

Comparação entre Pares

Variação de preço

Thermo Fisher Scientific Inc Previsão

Preço-alvo

By TipRanks

6.98% parte superior

Previsão para 12 meses

Média 614.41 USD 6.98%

Máximo 690 USD

Mínimo 520 USD

Com base em 19 analistas de Wall Street que oferecem metas de preço de 12 meses para Thermo Fisher Scientific Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

19 ratings

Comprar

Manter

Vender

Com base em 19 analistas que deram avaliações de ações para Thermo Fisher Scientific Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

66 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar